Indirect Comparison Of Daratumumab Monotherapy Versus Real-World Historical Control Data In Patients With Multiple Myeloma Who Are Heavily Pre-Treated And Highly Refractory
Abstract
Authors
J Diels A Lam T Ito Y Ng M Mehra I Khan